Travelers Diarrhea
📧 Sign up to get email alerts when something new happens for Travelers Diarrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea [Phase 3]
A Phase 3 trial evaluated bismuth subsalicylate for prevention of travelers' diarrhea; the study was terminated and its results have been po…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies [EARLY_Phase 1]
An early-phase 1 study to characterize the gastrointestinal pharmacokinetics of LMN-401 in individuals with ileostomies. The study is sponso…
-
FDA approval · 2023-01-26FDA Approved: LOPERAMIDE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.,)
FDA approved Advagen Pharma Ltd.'s original application for loperamide hydrochloride (a generic anti-diarrheal) to treat various forms of di…
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. [Phase 3]
Phase 3 trial update comparing two rifaximin tablets in travelers' diarrhea; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD [Phase 2]
A Phase 2 trial evaluated the safety and efficacy of bovine milk immunoglobulin targeting CS17 and CsbD for travelers' diarrhea; the study h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Dose-Finding Study of CS19 Expressing ETEC Challenge Strains [Phase 1]
Phase 1 dose-finding study to evaluate CS19-expressing ETEC challenge strains for travelers' diarrhea; the trial has completed.
-
FDA approval · 2016-11-03FDA Approved: LOPERAMIDE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Loperamide hydrochloride from Mylan Pharmaceuticals Inc., granting approval of a generic for…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea [Phase 4]
Phase 4 trial evaluating azithromycin with or without loperamide for the treatment of travelers' diarrhea; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2015-06-10Clinical Trial Update: Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea [Phase 4]
A Phase 4 clinical trial evaluating a single daily dose of rifaximin for travelers' diarrhea has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin [Phase 3]
Phase 3 trial evaluating rifaximin for the prophylaxis of travellers' diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study [Phase 3]
A Phase 3 pivotal efficacy study for a Travelers' Diarrhea vaccine sponsored by Intercell USA, Inc. has completed.
-
FDA approval · 2011-05-20FDA Approved: ANTI DIARRHEAL — Original Application (H E B)
FDA approved the original application for a generic anti-diarrheal product containing loperamide HCl, manufactured by H E B.
-
FDA approval · 2010-02-16FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s generic product Sulfamethoxazole and Trimethoprim as an Original Application (ANDA).